Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2019 |
Promyelocytic leukemia
|
disease |
|
Neoplastic Process
|
255
|
2
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Hantavirus infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
21
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Increased serum serotonin
|
phenotype |
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Elevated hepatic transaminase
|
phenotype |
|
Finding
|
212
|
9
|
0.100 |
None |
|
0 |
|
|
|
Palpitations, CTCAE
|
phenotype |
|
Finding
|
64
|
|
0.100 |
None |
|
0 |
|
|
|
Increased circulating ACTH level
|
phenotype |
|
Finding
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Lack of bowel sounds
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Dermatological manifestations of systemic disorders
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Atypical pulmonary carcinoid tumor
|
disease |
|
Neoplastic Process
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal pulmonary valve cusp morphology
|
phenotype |
|
Anatomical Abnormality
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Microvascular Angina
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
39
|
10
|
0.020 |
None |
1.000 |
2 |
1
|
2012 |
2018 |
Hypotension
|
phenotype |
Cardiovascular Diseases
|
Finding
|
125
|
2
|
0.100 |
None |
|
0 |
|
|
|
Tricuspid Valve Insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
60
|
5
|
0.100 |
None |
|
0 |
|
|
|
Heart Failure, Right-Sided
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
154
|
|
0.100 |
None |
|
0 |
|
|
|
Facial telangiectasia
|
phenotype |
Cardiovascular Diseases
|
Finding
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Right ventricular failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
28
|
|
0.100 |
None |
|
0 |
|
|
|
alpha-Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
37
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
alpha^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
92
|
16
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Multiple Endocrine Neoplasia Type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
145
|
156
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2018 |
Mental Retardation, X-Linked
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
141
|
13
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
42
|
32
|
0.100 |
None |
1.000 |
17 |
|
2011 |
2019 |
Huntington Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
978
|
115
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |